Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

Objective. The study aimed at characterizing the evolution of RA treatment with b/tsDMARDs in Romania, since the end of the SARS-CoV-2 pandemic and the national approval of JAKi. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases database between January 1st,...

Full description

Bibliographic Details
Main Authors: Elena Rezus, Claudiu C. Popescu, Corina Mogosan, Claudiu Avram, Razvan-Constantin Ionitescu, Ioana Felea, Ileana-Cosmina Filipescu, Catalin Codreanu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2023-09-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-07.pdf